These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34997995)

  • 1. Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo
    Clinic A; Asper A; Mittal A; Shome D; Parbhoo D; Thanzama J; Doshi K; Sachde N; Gaunkar R; Kapoor R; Thakkar R; Sion S; Shetty S; Kumar V; Parveen V; Singhal V
    J Cosmet Dermatol; 2022 Feb; 21(2):580-589. PubMed ID: 34997995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS-A prospective study.
    Kapoor R; Shome D; Doshi K; Patel G; Vadera S
    J Cosmet Dermatol; 2020 Oct; 19(10):2637-2646. PubMed ID: 33460214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QR 678 & QR678 Neo Vs PRP-A randomised, comparative, prospective study.
    Kapoor R; Shome D; Vadera S; Ram MS
    J Cosmet Dermatol; 2020 Nov; 19(11):2877-2885. PubMed ID: 32333510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 Neo
    Shome D; Kapoor R; Vadera S; Doshi K; Patel G; Mohammad Khan T
    J Cosmet Dermatol; 2021 Oct; 20(10):3299-3307. PubMed ID: 33826786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study.
    Kapoor R; Shome D
    J Cosmet Laser Ther; 2018 Oct; 20(6):369-379. PubMed ID: 29482481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of QR678 Neo
    Shome D; Kapoor R; Surana M; Vadera S; Shah R
    J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of efficacy of QR678
    Kapoor R; Shome D; Doshi K; Vadera S; Patel G; Kumar V
    J Cosmet Dermatol; 2020 Dec; 19(12):3270-3279. PubMed ID: 33016514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of QR678 and QR678 Neo
    Shome D; Kapoor R; Doshi K; Patel G; Vadera S; Kumar V
    J Cosmet Dermatol; 2022 Jan; 21(1):358-367. PubMed ID: 34825770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of efficacy of derma roller sizes vs topical application for administration of QR678 Neo® hair regrowth formulation in the treatment of androgenetic alopecia.
    Shome D; Tandel H; Kumar V; Kapoor R
    J Cosmet Dermatol; 2022 Nov; 21(11):6528-6530. PubMed ID: 36069359
    [No Abstract]   [Full Text] [Related]  

  • 10. The Efficacy and Safety of Dr. SKS Hair Booster Serum (a Cocktail of Micronutrients and Multivitamins) in Adult Males and Females With Androgenetic Alopecia: An Open-Label, Non-randomized, Prospective Study.
    Khare S
    Cureus; 2023 Apr; 15(4):e37424. PubMed ID: 37182050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
    Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
    Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newer approach in the treatment of seborrheic dermatitis with QR678® and QR678 Neo®-A prospective pilot study.
    Kapoor R; Shome D; Doshi K; Patel G; Tandel H; Kumar V
    J Cosmet Dermatol; 2023 Nov; 22(11):3078-3087. PubMed ID: 37621248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of platelet-rich plasma in androgenetic alopecia patients.
    Butt G; Hussain I; Ahmed FJ; Choudhery MS
    J Cosmet Dermatol; 2019 Aug; 18(4):996-1001. PubMed ID: 30393988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QR678 & QR678 Neo Hair Growth Formulations: A Cellular Toxicity & Animal Efficacy Study.
    Kapoor R; Shome D; Vadera S; Kumar V; Ram MS
    Plast Reconstr Surg Glob Open; 2020 Aug; 8(8):e2843. PubMed ID: 32983753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ; Dhurat RS
    Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Comparison of QR 678
    Shome D; Kapoor R; Doshi K; Patel G; Vadera S; Kumar V
    J Cosmet Dermatol; 2021 Jun; 20(6):1763-1765. PubMed ID: 33864424
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia.
    Tsunemi Y; Irisawa R; Yoshiie H; Brotherton B; Ito H; Tsuboi R; Kawashima M; Manyak M;
    J Dermatol; 2016 Sep; 43(9):1051-8. PubMed ID: 26893187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing hair growth in male androgenetic alopecia by a combination of fractional CO
    Huang Y; Zhuo F; Li L
    Lasers Med Sci; 2017 Nov; 32(8):1711-1718. PubMed ID: 28528395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.
    Zimber MP; Ziering C; Zeigler F; Hubka M; Mansbridge JN; Baumgartner M; Hubka K; Kellar R; Perez-Meza D; Sadick N; Naughton GK
    J Drugs Dermatol; 2011 Nov; 10(11):1308-12. PubMed ID: 22052313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.